ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 117 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q3 2019. The put-call ratio across all filers is 0.95 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $5,407,000 | -17.5% | 192,695 | 0.0% | 0.08% | -19.0% |
| Q3 2021 | $6,550,000 | -74.5% | 192,695 | -69.4% | 0.10% | -74.1% |
| Q2 2021 | $25,705,000 | +1.5% | 629,100 | 0.0% | 0.39% | -4.9% |
| Q1 2021 | $25,328,000 | -24.7% | 629,100 | +10.5% | 0.41% | -28.8% |
| Q4 2020 | $33,651,000 | +21.0% | 569,100 | -0.5% | 0.57% | +4.6% |
| Q3 2020 | $27,816,000 | +192.6% | 571,990 | +191.1% | 0.54% | +183.9% |
| Q2 2020 | $9,507,000 | +72.7% | 196,500 | -0.8% | 0.19% | +46.6% |
| Q1 2020 | $5,504,000 | +80.5% | 198,120 | +94.3% | 0.13% | +142.6% |
| Q4 2019 | $3,050,000 | +71.3% | 101,950 | +76.9% | 0.05% | +68.8% |
| Q3 2019 | $1,781,000 | +5.4% | 57,630 | +64.7% | 0.03% | +6.7% |
| Q2 2019 | $1,690,000 | – | 35,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,377,665 | $12,958,274 | 12.23% |
| Eagle Health Investments LP | 1,214,860 | $6,620,987 | 1.46% |
| Matrix Capital Management Company, LP | 11,572,590 | $63,070,616 | 0.76% |
| Aristotle Atlantic Partners, LLC | 3,058,206 | $16,667,223 | 0.67% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $163,465,709 | 0.66% |
| Pier Capital, LLC | 719,067 | $3,918,915 | 0.63% |
| DDD Partners, LLC | 783,697 | $3,385,571 | 0.49% |
| ARK Investment Management | 11,509,308 | $62,725,728 | 0.48% |
| Nikko Asset Management Americas, Inc. | 6,570,939 | $35,680,199 | 0.43% |
| Triatomic Management LP | 102,889 | $560,745 | 0.39% |